<prompt> Please answer with one of the option in the bracket. Write reasoning in between . Write answer in between .Q:A 50-year-old man comes to the physician for his annual health maintenance examination. The patient feels well. He has a history of hypertension, for which he currently takes lisinopril. He has smoked a pack of cigarettes daily for 20 years. He drinks 56 beers on weekends. He is 181 cm tall 5 ft 11 in, weighs 80 kg 176.4 lbs; BMI is 24.6 kgm2. His pulse is 75min, blood pressure is 14085 mm Hg, and respirations are 18min. Physical examination is unremarkable. Laboratory studies show:Total cholesterol 263 mgdLHigh-density lipoprotein cholesterol 36 mgdLTriglycerides 180 mgdLIn addition to dietary and lifestyle modification, administration of which of the following agents is the most appropriate next step in management?? A: Cholesterol absorption inhibitor, B: Proprotein convertase subtilisin kexin 9 inhibitor, C: HMG-CoA reductase inhibitor, D: Bile acid resins, E: Peroxisome proliferator-activated receptor alpha activator,  <response>: This is a question about choosing the most appropriate medication for a 50-year-old man with hypertension, a history of smoking, and mildly elevated cholesterol levels. The key findings are a total cholesterol of 263 mgdL, HDL of 36 mgdL, and triglycerides of 180 mgdL. His LDL level is not provided, but can be estimated using the Friedewald equation to be approximately 190 mgdL. Based on his cardiovascular risk factors hypertension, smoking, male sex, age, he meets criteria for starting a statin medication according to major guidelines. The question is asking for the most appropriate next step in management in addition to lifestyle changes. Of the choices provided, an HMG-CoA reductase inhibitor statin would be the best option to reduce his cardiovascular risk by lowering his LDL cholesterol.C: HMG-CoA reductase inhibitor 